- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: A Baffling Case of Zika, Rising Premiums in California
Experts say Covered California is making up for coverage that was underpriced the last 2 years, and Maryland Medicaid officials create an uproar by changing the preferred opioid addiction treatment.
Health officials in Utah are baffled by a case of Zika virus that did not appear to have been transmitted by known routes: a mosquito bite or sexual contact. According to The New York Times, the patient was a family member and caregiver for an older man in Salt Lake County who contracted Zika while traveling abroad. The older man had other health problems and later died; the caregiver has recovered. CDC is assisting in the investigation.
Covered California will raise premiums 13.2% for 2017, a steep rise that reflects the fact that policies were underpriced. The largest state-level exchange had been praised for keeping increases to around 4% the past 2 years. But rising medical costs and the lapsing of federal programs to help insurers with pricy claims made the increase inevitable, according to California HealthLine.
Maryland Medicaid officials have sparked a debate over how to best treat opioid addiction. They removed Suboxone film from the state’s formulary after prison officials said too many strips were being smuggled in and resold on the black market. The trouble with Suboxone, prison officials say, is that it is itself an opioid, and the strips were chopped up into small pieces that were easy to hide. Medicaid replaced the film with tablets, but doctors say this formulation isn’t as effective.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
